Suppr超能文献

自发性高血压大鼠的肾激肽释放酶-激肽系统

The renal kallikrein-kinin system in spontaneously hypertensive rats.

作者信息

Bönner G, Unger T, Rascher W, Speck G, Ganten D, Gross F

出版信息

Agents Actions. 1984 Oct;15(3-4):111-8. doi: 10.1007/BF01972335.

Abstract

In male spontaneously hypertensive rats (SHRSP) of the stroke prone strain (Okamoto) and in normotensive Wistar-Kyoto rats (WKY) urinary kallikrein excretion was investigated at different age and at drug-induced diuresis. In rats of both strains from 7th till 19th week of age urinary kallikrein excretion increased with age. In SHRSP of 7th till 11th week of age kallikrein excretion was higher than in WKY rats, while it was lower in the 48-week-old SHRSP. No correlation was found between urinary kallikrein excretion and systolic blood pressure. In SHRSP and WKY rats a similar daily rhythm of kallikrein excretion in urine was found being high in the early morning and low in the afternoon. Kallikrein excretion correlated significantly with urine volume. The loop diuretic bumetanide (4 and 40 mg/kg) induced diuresis and natriuresis in both strains, however more marked in the WKY rats than in the SHRSP. Urinary kallikrein excretion, however, showed in both strains the same biphasic course with a short lasting increase and a secondary decrease. Thus, in the average urinary kallikrein excretion was not effected by the drug. Prolonged treatment with furosemide over 5 days (125 mg/kg) resulted in an increase in kallikrein excretion in urine, more pronounced in the WKY rats than in the SHRSP. The observed results suggest that renal kallikrein-kinin system is not involved in the development of spontaneous hypertension as a pathogenetic factor, but rather is influenced by other factors like hormone interactions, i.e. mineralocorticoids and catecholamines, as well as renal function and acute changes in urine flow.

摘要

在易发生中风的雄性自发性高血压大鼠(SHRSP,冈本品系)和正常血压的Wistar - Kyoto大鼠(WKY)中,研究了不同年龄以及药物诱导利尿情况下的尿激肽释放酶排泄情况。在这两种品系的大鼠中,从7周龄到19周龄,尿激肽释放酶排泄量随年龄增加。在7周龄至11周龄的SHRSP中,激肽释放酶排泄量高于WKY大鼠,而在48周龄的SHRSP中则较低。未发现尿激肽释放酶排泄与收缩压之间存在相关性。在SHRSP和WKY大鼠中,发现尿中激肽释放酶排泄具有相似的日节律,清晨时高,下午时低。激肽释放酶排泄与尿量显著相关。髓袢利尿剂布美他尼(4和40mg/kg)在两种品系中均诱导利尿和利钠作用,但在WKY大鼠中比在SHRSP中更明显。然而,两种品系的尿激肽释放酶排泄均呈现相同的双相过程,先是短暂增加,然后是继发性减少。因此,平均而言,尿激肽释放酶排泄不受该药物影响。用呋塞米连续治疗5天(125mg/kg)导致尿中激肽释放酶排泄增加,在WKY大鼠中比在SHRSP中更显著。观察结果表明,肾脏激肽释放酶 - 激肽系统作为致病因素不参与自发性高血压的发生发展,而是受其他因素影响,如激素相互作用,即盐皮质激素和儿茶酚胺,以及肾功能和尿流的急性变化。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验